Fatty acid amide hydrolase in prostate cancer: association with disease severity and outcome, CB1 receptor expression and regulation by IL-4
about
Endocannabinoid system as a regulator of tumor cell malignancy - biological pathways and clinical significanceAnticancer mechanisms of cannabinoidsEndocannabinoids as Guardians of MetastasisPotential upstream regulators of cannabinoid receptor 1 signaling in prostate cancer: a Bayesian network analysis of data from a tissue microarray.Tumour Cannabinoid CB(1) receptor and phosphorylated epidermal growth factor receptor expression are additive prognostic markers for prostate cancer.α-synuclein reactive antibodies as diagnostic biomarkers in blood sera of Parkinson's disease patients.High levels of γ-glutamyl hydrolase (GGH) are associated with poor prognosis and unfavorable clinical outcomes in invasive breast cancerAssociation between cannabinoid CB₁ receptor expression and Akt signalling in prostate cancer.Regulation of circulating endocannabinoids associated with cancer and metastases in mice and humans.Monoacylglycerol lipase exerts dual control over endocannabinoid and fatty acid pathways to support prostate cancer.The endocannabinoid system and cancer: therapeutic implication.The influence of monoacylglycerol lipase inhibition upon the expression of epidermal growth factor receptor in human PC-3 prostate cancer cells.Prognosis of treatment response (pathological complete response) in breast cancer.The endocannabinoid system and sex steroid hormone-dependent cancers.Update on the endocannabinoid system as an anticancer target.The endocannabinoid system in prostate cancer.Receptor-dependent and receptor-independent endocannabinoid signaling: a therapeutic target for regulation of cancer growth.The evolving role of the endocannabinoid system in gynaecological cancer.The cannabinoid WIN 55,212-2 prevents neuroendocrine differentiation of LNCaP prostate cancer cells.Antitumorigenic targets of cannabinoids - current status and implications.Phyto-, endo- and synthetic cannabinoids: promising chemotherapeutic agents in the treatment of breast and prostate carcinomas.Systematic review of the potential role of cannabinoids as antiproliferative agents for urological cancersEffects of tumour necrosis factor α upon the metabolism of the endocannabinoid anandamide in prostate cancer cells.18F-MK-9470 PET imaging of the type 1 cannabinoid receptor in prostate carcinoma: a pilot study.Cannabinoids Modulate Neuronal Activity and Cancer by CB1 and CB2 Receptor-Independent Mechanisms.INSIGHT ON THE IMPACT OF ENDOCANNABINOID SYSTEM IN CANCER: A REVIEW.The current state and future perspectives of cannabinoids in cancer biology.
P2860
Q26739831-7D4A76B5-C258-4CCC-965A-0CC2A23CF4E1Q26750399-FFDBD12F-073A-4212-90B8-14290323FE8AQ26766163-0783DBF5-BFB4-401D-AE35-3F1EA3AED7D4Q30830112-A832D3DB-5FF1-43B5-9C63-0518C6F97FDBQ33784488-2430CBA1-CDD1-46D5-AE35-3B056654EA7FQ33889446-54841BD3-E42E-4A5A-B121-EC6B75F627C2Q34572152-48D2DFE0-455E-40A5-B42F-DCCEB723A72EQ34766747-A506B89D-CD06-439B-B0EE-C8238471D993Q34781231-5E4B16F7-D6EB-4B3E-A59F-57918E1DEF74Q35146525-FA09057C-F0E8-4C48-8CCC-363626D3009AQ35193299-7CDEA579-B5FC-4BE5-988C-6F0A24C766E8Q35205032-3B9DFD55-5530-47BB-B4BA-2C1D726D496CQ35971135-73881DFA-91A0-47F9-A74C-E774323D0D4DQ37393042-C916E97A-A8DA-421B-8713-D79E92795246Q37829751-DF26B132-B8D3-4F68-926C-AB25CE4042F3Q37930973-1DB82D79-64B8-4D27-826F-A32F6C4CFDB0Q38052298-C675364F-8A9F-493F-8872-36DF639232C6Q38469671-B4DC5E1A-6773-4B0D-8E11-4F8291B43A9DQ38763212-566EB477-7C7C-435F-A045-F2A4EF0FDE88Q38806270-E3947CDB-E396-4DA8-B7B2-3B6DC7E4351AQ38955546-A453BA81-617A-4BF1-A7EE-F4758881A3B9Q39155538-4228BE6E-28C7-48B4-995B-8733D91F0DFEQ41068663-6AD8A945-F163-484E-9A61-8A87522D9D9DQ42564268-175ED93E-D67C-4E6A-888A-7E15764272F6Q42700473-F206F2AD-07A5-4478-87D1-D6D46449CFABQ52583978-DCFA7162-054F-4BFC-AE12-652197E71D1BQ55415383-B378EF08-3DD9-414B-8A34-82C8CE9A80FD
P2860
Fatty acid amide hydrolase in prostate cancer: association with disease severity and outcome, CB1 receptor expression and regulation by IL-4
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Fatty acid amide hydrolase in ...... ression and regulation by IL-4
@ast
Fatty acid amide hydrolase in ...... ression and regulation by IL-4
@en
type
label
Fatty acid amide hydrolase in ...... ression and regulation by IL-4
@ast
Fatty acid amide hydrolase in ...... ression and regulation by IL-4
@en
prefLabel
Fatty acid amide hydrolase in ...... ression and regulation by IL-4
@ast
Fatty acid amide hydrolase in ...... ression and regulation by IL-4
@en
P2093
P2860
P1433
P1476
Fatty acid amide hydrolase in ...... ression and regulation by IL-4
@en
P2093
Anders Bergh
Christopher J Fowler
Emma Persson
Peter Hammarsten
Pär Stattin
Torvald Granfors
P2860
P304
P356
10.1371/JOURNAL.PONE.0012275
P407
P577
2010-08-19T00:00:00Z